Navigation Links
Vaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Settlement in Second Bellwether Trial in Federal C.R. Bard Mesh Litigation

New York, NY (PRWEB) August 22, 2013

C.R. Bard Inc. has agreed to settle with the plaintiff in the second vaginal mesh lawsuit ( that was to head to trial over products from its line of Avaulta implants in a federal litigation underway in the Southern District of West Virginia, Bernstein Liebhard LLP reports.

The case, which was scheduled to serve as the second of four bellwether trials in that proceeding, involved claims from a North Carolina woman who allegedly suffered permanent vaginal mesh injuries caused by the company’s Avaulta Solo Anterior Synthetic Support System. According to a report from, the first bellwether trial ended a week earlier with a $2 million damage award to the plaintiff from a jury in West Virginia who found C.R. Bard liable for the injuries the plaintiff sustained as a result of her Avaulta Plus pelvic mesh device.* (In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, MDL No. 2187)

“News of this settlement is of great interest to our firm. We continue to hear from women who have allegedly suffered injuries caused by transvaginal mesh not only manufactured by C.R. Bard, but by other transvaginal mesh manufacturers as well. Many of their injuries mirror those claimed in this lawsuit,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is actively filing transvaginal mesh lawsuits on behalf of women who suffered mesh erosion, scarring, pain, infection and other complications that may have been caused by transvaginal mesh. Bernstein Liebhard LLP partner Jeffrey S. Grand, is a member of the Plaintiffs’ Steering Committee in the federal litigation involving products from C.R. Bard.

Vaginal Mesh Lawsuits
According to, C.R. Bard is currently facing more than 5,000 transvaginal mesh lawsuits, many of which have been filed in the federal proceeding underway in the U.S. District Court, Southern District of West Virginia.** The first bellwether trial in the litigation concluded on August 15th with a jury in West Virginia awarding $2 million to a woman who suffered permanent injury, physical deformity and other serious injuries stemming from the company’s Avaulta Plus device. During the trial, her lawyers argued that C.R. Bard officials were aware that a plastic resin used in products from its line of Avaulta implants was considered unsuitable for permanent implantation in humans by its manufacturer, but produced certain transvaginal mesh devices with it anyway.

The federal litigation involving C.R. Bard mesh products is among several proceedings currently underway in the Southern District of West Virginia, including: In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; and In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327. Firm partner, Jeffrey S. Grand, is currently serving on the Plaintiffs’ Steering Committees for each of these federal litigations.

At the state level, Mr. Grand is also serving as Co-Liaison Counsel in two consolidated litigations involving products from C.R. Bard and Ethicon established in New Jersey’s Atlantic County Superior Court. He was also a member of the trial team on the proceeding’s first Ethicon trial, which ended in March with an $11 million damage award to the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10).

The lawyers at Bernstein Liebhard LLP are currently offering free and confidential case evaluations to women who may have been injured as a result of transvaginal mesh. Read more about vaginal mesh lawsuits by visiting Bernstein Liebhard LLP’s website. Contact the Firm directly by calling 800-511-5092.

*, August 21, 2013;
**, August 15, 2013;

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. C.R. Bard Settles Its Second Transvaginal Mesh Case in West Virginia Multidistrict Litigation, Notes Parker Waichman LLP
2. Transvaginal Mesh Lawsuit Update: Rottenstein Law Group LLP Comments on Bard Mesh Trial Settlement in W. Va.
3. Transvaginal Mesh Device Caused California Woman Serious Injuries, Alleges Parker Waichman LLP in Lawsuit
4. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Start of Second Bellwether Trial in Federal C.R. Bard Litigation
5. Transvaginal Mesh Lawsuit News: New CR Bard Mesh Trial Scheduled for Aug. 19, Rottenstein Law Group LLP Reports
6. Vaginal Mesh Lawsuit News: Wright & Schulte LLC Applaud $2 Million Verdict in C.R. Bard Transvaginal Mesh Lawsuit Trial
7. Vaginal Mesh Lawsuits Proceed Against Ethicon, as Bernstein Liebhard LLP Notes Order for Discovery Conferences in Federal Ethicon Litigation
8. Vaginal Mesh Lawsuit News: Plaintiff in First Federal Bellwether Trial of C.R. Bard Vaginal Mesh Lawsuit Awarded $2 Million
9. Jury Awards Transvaginal Mesh Patient $2M, Finding that C.R. Bard Failed to Warn of the Dangers of Its Avaulta Pelvic Mesh Device, Notes Parker Waichman LLP
10. Vaginal Mesh Lawsuit News: Jury Awards $2 Million to Plaintiff in First C.R. Bard Vaginal Mesh Lawsuit, Reports Alonso Krangle LLP
11. Transvaginal Mesh Lawsuit News: Rottenstein Law Group LLP Responds to $2 Million Bard Mesh Trial Verdict
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag Specialties, Inc. (BSI) ... for the Nutraceutical Specialties products into oral solid dosage in the over the ... “We are pleased to announce our expanded distribution agreement with ASI.” said Steve ...
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, Va., is ... "My last baby had high blood pressure due to loud noises," she said, "so ... babies from noise pollution as well as radio waves and microwaves." , The baby ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its ... specializing in independent living, assisted living and all other retirement options. Support for ... awareness and research remains a top priority. , So it’s no surprise ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... of DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. The ... and technical experience available within DataTrade to extend the services currently provided by ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015   Nuance Communications, Inc. ... National Decision Support Company (NDSC) today jointly announced ... collaboration capabilities that utilize the American College of Radiology,s ... provider organizations to comply with current and emerging ... --> By combining clinical decision support, ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate the ... 57 th American Society of Hematology (ASH) Annual ... myelomas as well as supportive care, including key findings ... personalized cell therapies. The ASH Annual Meeting will be ... . Novartis Oncology . "We will be ...
(Date:11/30/2015)... Israel , Nov. 30, 2015  OticPharma, Ltd., ... and developing innovative therapies for ear, nose, and throat ... A. Katkin as chairman of the company,s board ... executive officer for OticPharma, Ltd.  "Keith brings a wealth ... will be able to share this experience and provide ...
Breaking Medicine Technology: